Please login to the form below

Not currently logged in
Email:
Password:

Ritter Pharmaceuticals appoints new CMO

AnnKatrin Petersen-Jappelli to strengthen company

Ritter Pharmaceuticals has appointed AnnKatrin Petersen-Jappelli as chief medical officer.

Ritter is currently developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.

Michael Step, CEO of Ritter Pharmaceuticals, said: “The additions of Dr Petersen-Jappelli further strengthens Ritter Pharmaceuticals' management with a leader who has significant experience in both the biotech and pharmaceutical industries, with a focus on treating gastrointestinal diseases.

Petersen-Jappelli joins Ritter having spent over 25 years in the pharmaceutical and biotechnology industry. Before this she served at Santarus as scientific research and clinical development leader of a phase III program for traveler's diarrhoea.

She said: “Joining Ritter Pharmaceuticals is an exciting opportunity to be part of a unique and innovative company that is working to treat gastrointestinal disease through the modulation of the gut microbiome.

“I believe my experience in product development coupled with my research capabilities will be a great combination for this role and I look forward to working with the team as we advance our science, build our product portfolio, and bring therapeutics to market that have the potential to provide significant relief to patients suffering from gastrointestinal diseases.”

9th October 2015

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...